Oct 20, 6:56 AM ET
Kroger outlined a multi-year plan called Build America's Favorite Grocer and set new long-term financial targets through 2029, including 3%-6% adjusted EBITDA growth and 7%-11% adjusted net EPS growth for FY2027 through FY2029, excluding the pending Giant Eagle acquisition. The company reaffirmed its full-year 2026 guidance from its second quarter earnings, and replaced its prior 8%-11% total shareholder return target with the EPS-only target.
- Targets approximately 3% comparable sales growth in 2029, excluding fuel and pharmacy
- Targets 3%-6% adjusted EBITDA CAGR and 7%-11% adjusted net EPS CAGR for FY2027 through FY2029
- Reaffirms 2026 full-year guidance provided at second quarter earnings
- New EPS target replaces prior 8%-11% total shareholder return target, which included dividend yield
Read the filing on SEC.gov ↗
Sep 11, 6:59 AM ET
Kroger reported second-quarter 2026 sales of $34.6 billion, up from $33.9 billion a year earlier, and GAAP earnings of $1.05 per diluted share versus $0.91. The company kept its full-year 2026 adjusted EPS guidance of $5.10 to $5.30 but lowered its identical sales without fuel guidance to 0.2% to 0.8% from 1.0% to 2.0%, and adjusted FIFO operating profit fell slightly year over year.
- Q2 2026 adjusted EPS was $1.09 versus $1.04 a year earlier; adjusted FIFO operating profit was $1,076 million versus $1,091 million.
- Identical sales without fuel rose 0.2% in the quarter, compared with 3.4% a year earlier.
- Full-year 2026 adjusted EPS guidance of $5.10 to $5.30 was reaffirmed; identical sales guidance was cut to 0.2% to 0.8%.
- Kroger repurchased $1.0 billion of shares in the quarter, with about $800 million left on the $2 billion authorization, and will host an investor update on October 20, 2026.
Read the filing on SEC.gov ↗
Sep 2, 4:48 PM ET
Kroger appointed Mark Ibbotson, 63, as Executive Vice President and Chief Store Operations Officer, effective September 14, 2026. He previously held roles at Walmart U.S. and Asda, and has been a Senior Advisor for McKinsey & Company for the last four years. The filing sets his base salary at $1,000,000 and a current total target long-term equity value of $5 million.
- Appointment made August 31, 2026; effective September 14, 2026.
- Annual base salary of $1,000,000 and an incentive bonus target of 110% of base salary, pro-rated for 2026.
- Equity package includes $1.25 million in restricted shares, $1.25 million in performance units under the 2026-2028 plan, and $1 million in restricted shares, all to be awarded in December 2026.
- Prior experience at Walmart U.S. and Asda since 2004, including Executive Vice President of Central Operations and Realty.
Read the filing on SEC.gov ↗
Jun 26, 4:15 PM ET
Kroger said Chairman Ronald L. Sargent will cease serving as a Company employee effective July 1, 2026, and will continue as Non-Executive Chairman of the Board, with updated director pay starting the same day. At the June 25, 2026 annual meeting, shareholders elected all ten directors, approved executive compensation on an advisory basis, ratified PricewaterhouseCoopers LLP as auditor, approved a revised long-term incentive plan, and rejected a shareholder proposal on GHG emissions reductions.
- Effective July 1, 2026, Ronald L. Sargent (Chairman since March 2025) ceases to be an employee and continues as Non-Executive Chairman.
- From July 1, 2026, each non-employee director receives a $115,000 annual cash retainer and annual incentive shares valued at about $215,000; Sargent also gets about $250,000 in annual incentive shares for chairman service.
- Sargent received 468,967,642 votes for and 23,737,119 against in his director election.
- The GHG emissions shareholder proposal was rejected, with 85,776,050 for and 404,190,678 against.
Read the filing on SEC.gov ↗
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
